• Profile
Close

Risk of myocardial infarction and death after noncardiac surgery performed within the first year after coronary drug-eluting stent implantation for acute coronary syndrome or stable angina pectoris

The American Journal of Cardiology Oct 02, 2021

Thim T, Egholm G, Kristensen SD, et al. - Patients suffering from acute coronary syndrome (ACS) and stable angina pectoris (SAP) who had surgery between 1 and 12 months post-stent implantation were found to have a risk for myocardial infarction (MI) and death that was similar to the risk noted in surgical patients without coronary artery disease.

  • This study included patients with drug-eluting stent implantation for ACS (n = 2,291) or SAP (n = 1,804) who had noncardiac surgery vs a matched cohort from the general population without known coronary artery disease.

  • ACS patients exhibited markedly elevated 30-day MI risk when surgery was done within 1 month post-stenting, whereas mortality was comparable.

  • When surgery was done between 1 and 12 months post-stenting, a low 30-day absolute risk for MI was evident which was still higher than the comparison cohort, whereas the mortality risks were similar.

  • Although low 30-day MI risk was observed in SAP patients, it was still higher than in the comparison cohort, whereas mortality risks were similar.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay